Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-30T21:36:08.532Z Has data issue: false hasContentIssue false
  • English
  • Français

When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia — ADDENDUM

Published online by Cambridge University Press:  10 June 2019

Evangelos Papanastasiou ,
James M. Stone  and
Sukhi Shergill
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Addendum
Information
The British Journal of Psychiatry , Volume 215 , Issue 2 , August 2019 , pp. 507
Copyright
Copyright © The Royal College of Psychiatrists 2019 

There was an oversight regarding the acknowledgement of funding from the European Research Council, which was a contractual obligation for the funding. Professor Sukhi Shergill was funded by an ERC Consolidator Award.

References

Papanastasiou, E, Stone, JM, Shergill, S. When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia. Br J Psychiatry 2013; 202: 91–93.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.